Because it’s such an evolving area of medicine, reimbursement for pharmacogenomic testing varies across the country – and impacts clinical decisions made on a daily basis. Take a look at IGNITE’s overview of which Medicare Administrative Contractor (MAC) serves each state and which genetic tests are covered by the MAC, as well as the associated indication and non-covered indication for each non-medically necessary pharmacogenetic test.